My first trip to India was to participate in a workshop on health technology assessment (HTA) organized by the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) and the Health Intervention and Technology Assessment Program (HITAP) in Puducherry, India on 3-5 October 2019.

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car

In the Philippines, use of HTA is not completely new; there have been prior efforts to institutionalize a fair and systematic process of generating policy-relevant evidence to inform coverage of health services, such as listing of drugs in the national formulary and new benefits in the national soci

17-2-021-2559(2)economic impact,health impact,health technology,HITA,HITAP,HTA,Unsafe food,การประเมินเทคโนโลยีและนโยบายด้านสุขภาพ,ประเมินผลกระทบ,อาหารไม่ปลอดภัย

In 2018-19, HITAP collaborated with the University of Strathclyde to conduct a study on assessing the value of HTA agencies as part of the Evaluating the Value of a Real-world HTA agency (EVORA) project. The three outputs from this study are an Excel-based simulation model, a logic model on the impact of HTA agencies and a review of literature. The

As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about

\"First Step”, a program evaluation report, assessing HITAP’s two-year efforts and providing recommendations for further development of HITAP. This program evaluation was conducted by four external evaluators including Prof. John Cairns, Dr. Kalipso Chalkidou, Prof. Paibul Suriyawongpaisal, and Dr. Jirawat Panpiemras. Moreover, Prof. Mark Sculp

Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla

On 2nd – 6th October 2023, HITAP hosted a topic selection workshop and communication training for relevant HTA stakeholders in Ghana, with the support of the Access and Delivery Partnership (ADP). This workshop was held with the aims to increase awareness of health technology ass